Molecular Vision: Magaña-Guerrero, Mol Vis 2025; 31:368-378. Table 2

Table 2. Cytokine quantification* in vitreous from DME and PDR.

Cytokine	DME	PDR	Cytokine	DME	PDR
*CCL2*	0.23	8.15 ↑	PDGF	0.06	0.76
*CXCL5*	0.42	7.20 ↑	TPO	0.04	0.75
*Angiogenin*	0.67	3.80 ↑	TGF-β	0.01	0.69
TIMP1	0.15	1.99	CCL5	0.07	0.64
Leptin	0.09	1.65	IGF1	0.08	0.63
TIMP2	0.21	1.61	VEGF	0.06	0.63
VEGFD	0.06	1.15	IL-8	0.02	0.62
CXCL1	0.12	1.09	PGF	0.02	0.57
EGF	0.07	0.95	IL-6	0.00	0.20
IFN-γ	0.09	0.82	bFGF	0.00	0.07

*Results are expressed as a fold increase over surrogate controls. ↑ elevated cytokine levels, DME, diabetic macular edema; PDR, proliferative diabetic retinopathy; TIMP1, tissue inhibitor of metalloprotease 1; VEGF, vascular endothelial growth factor; EGF, epidermal growth factor; IFN-γ, interferon γ; PDGF, platelet-derived growth factor; TPO, thrombopoietin; TGF-β, transforming growth factor β; IGF1, insulin-like growth factor; PGF, placental growth factor; bFGF, basic fibroblast growth factor.